Glenview Capital Management, LLC Edwards Lifesciences Corp Transaction History

Glenview Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $226,766 - $295,110	-3,375 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$57.54 - $76.95 $778,573 - $1.04 Million	-13,531 Reduced 80.04%	3,375 $233,000
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $886,043 - $1.37 Million	16,906 New	16,906 $3.19 Million

1,375

454M

3.86M

3.32M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $57.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Glenview Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Glenview Capital Management, LLC with notifications on news.